Not provided
Not provided
Not provided
Not provided
Not provided
PI has left the institution
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fisher and Paykel Healthcare | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Obstructive sleep apnea (OSA) is a prevalent disorders characterized by intermittent obstructions of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) has been shown to be the most efficacious treatment for OSA. It consists of a small device that provides positive airway pressure delivered by a mask attached to the patients nose/mouth.
The primary purpose of this study is to evaluate the multinight (MNT) algorithm on patients with Obstructive Sleep Apnea (OSA) over 45 nights while using a CPAP machine at home. The researchers are evaluating the performance of the existing algorithm as well as capturing the data to make enhancements.
Two main stages of this algorithm will be assessed:
i. Fast Track (FT) stage. In the FT stage the aim is to assess if the algorithm reliably and timely reaches approximate therapeutic pressure levels.
ii. Slow Titration (ST). In the Slow Titration stage the aim is to assess if data samples have been appropriately collected in a pressure range so that the therapeutic pressure can be inferred according to the algorithm proposed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MNT Algorithm | Experimental | All participants will be monitored using an existing (FDA approved) CPAP machine that has been modified to be externally controlled by a computer with the MNT algorithm, for titration. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CPAP machine with MNT algorithm | Other | The multinight (MNT) algorithm will be evaluated on patients with Obstructive Sleep Apnea (OSA) over multiple nights while using CPAP in the home for a total of 45 days. In particular the main goal is to assess the behavior of the two main stages of the algorithm:
|
| Measure | Description | Time Frame |
|---|---|---|
| Difference in number of residual events between high and low pressure levels | Residual events are represented by a given sleep disordered breathing index SDBIndex | 45 days |
| Pressure level obtained during the MNT Fast Track stage | 7 days | |
| Number of days required to reach Fast Track pressure | 7 days | |
| Number of times the algorithm returns to Slow Track from the Fast Track stage | 45 days | |
| Variance in average obstruction of the upper airway during sleep measured by Obstruction Index (OI) | 3 hours | |
| Difference between pressure derived from multinight algorithm (PMNT) and Fast Track pressure | 45 days | |
| Difference between PMNT and sleep lab diagnosed CPAP pressure | 45 days | |
| Number of residual events while using the PMNT function | 45 days |
| Measure | Description | Time Frame |
|---|---|---|
| Average comfort rating using CPAP with multinight automated titration | 45 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
° Vulnerable subjects
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Rapoport, MD | NYU Langone Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York University School of Medicine | New York | New York | 10016 | United States |
Not provided
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| ID | Term |
|---|---|
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D020919 | Sleep Disorders, Intrinsic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| D020920 |
| Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |